Market Overview

  • An oncolytic virus is a genetically engineered or naturally occurring virus that can imitate in selected terms and kill cancer cells without harming the normal tissues. Oncolytic Virus therapy is a new therapeutic approach for treating cancer and shown promising results globally.

  • Global Oncolytic virus therapy market value is accounted for USD xx billion in 2018 and is expected to grow at a CAGR of 19.32% to reach USD xx billion by 2026.

 

Market Dynamics

  • The rising prevalence of cancer cases and increasing development of cancer-treating therapies such as an oncolytic virus is driving the market growth globally.

  • Technological developments such as natural killer cells and use of combination therapies are also driving the market growth. Further ongoing development of virus therapies globally, which are in the pipeline will further enhance the growth of oncolytic virus therapy market in the forecast period.

  • The immune reaction to the virus based therapies by repeated administration of therapeutics for treating cancer is a critical restraint that hampering market growth.

  • The high cost of oncolytic virus therapy is further affecting market growth, especially in developing countries.

  

Market Segmentation

  • Global Oncolytic Virus Therapy Market is segmented by application type, by drug class, and therapy type.

  • By application, the market is segmented into Prostate cancer, Melanoma, Ovarian Cancer, Breast Cancer, and others. Melanoma is accounted for the largest share as most of the cancer therapies are developed for Melanoma cancers. They are increasing prostate cancer cases also leading to a steady growth rate in prostate cancer therapies in recent years.

  • By Drug class the market is segmented into Onyx-15, Talimogene laherparepvec, Reolysin, RIGVIR. Talimogene laherparepvec is the most significant drug class that accounted for a significant share in the market and is mainly due to its large penetration in cancer treatment.

 

Geographical Share

  • By Geography the market is segmented into North America, South America, Europe, Asia Pacific and rest of the World. North America is the leading market globally and is mainly due to increased cancer cases associated with hectic lifestyles. Well-developed healthcare infrastructure is further supported by the growth in the region.

 

Market Key Companies

  • Oncolytic Virus Therapy is highly concentrated among a few key players such as Amgen, Shanghai Sunway Biotech Co. Ltd, and RIGVIR. Companies in the industry operate on low-profit margins, which is likely to worsen further during the forecast period. Industry players are focusing on implementing inorganic growth strategies to expand their presence in the market.

 

Why Purchase the Report?

  • Visualize the composition of the global Oncolytic Virus Therapy market across each indication, in terms of type and treatment options, highlighting the critical commercial assets and players.

  • Identify commercial opportunities in global Oncolytic Virus Therapy market by analyzing trends and co-development deals.

  • Excel data sheet with thousands of data points of the global Oncolytic Virus Therapy market.

  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

  • Product mapping in excel for the principal products of all major market players.

 

Target Audience

  • Equipment Suppliers/ Buyers

  • Service Providers/ Buyers

  • Industry Investors/Investment Bankers

  • Education & Research Institutes

  • Research Professionals

  • Emerging Companies

  • Manufacturers

1.Oncolytic Virus Therapy Market - Scope and Methodology

1.1 Research Methodology

1.2 Scope of the market

2. Oncolytic Virus Therapy Market - Industry Trends

2.1 Key Market trends and Developments

3. Oncolytic Virus Therapy Market - Outlook

3.1 Drivers

3.2 Restraints

3.3 Porter’s Five Forces Analysis

4. Oncolytic Virus Therapy Market - Clinical Trial Analysis

5. Oncolytic Virus Therapy Market - Product Pipeline Analysis

6. Oncolytic Virus Therapy Market Segmentation Analysis

6.1 By Application

6.1.1 Prostate cancer

6.1.2. Melanoma

6.1.3 Ovarian Cancer

6.1.4. Breast Cancer

6.1.5. Other

6.2. By Drug Class

6.2.1. Onxy-15

6.2.2. Talimogene laherparepvec

6.2.3. Reolysin

6.2.4. RIGVIR

6.2.5. Others

6.3. By Therapy Type

6.3.1. HSV-based Oncolytic Viruses

6.3.2. Adenoviruses-based Oncolytic Viruses

6.3.3. Vaccinia Virus-based Oncolytic Viruses

6.3.4. Vesicular Stomatitis Virus-based Oncolytic Viruses

6.3.5. Newcastle Disease Virus-based Oncolytic Viruses

 7. Oncolytic Virus Therapy Market - Regional, Country-level Analysis

7.1. North America

7.1.1. U.S.A

7.1.2. Mexico

7.1.3. Canada

7.2. Europe

7.2.1. Germany

7.2.2. U.K.

7.2.3. France

7.2.4. Rest of Europe

7.3. South America

7.3.1. Brazil

7.3.2. Argentina

7.3.3. Rest of South America

7.4. Asia Pacific

7.4.1. China

7.4.2. India

7.4.3. Japan

7.4.4. Rest of Asia Pacific

7.5. Rest of the World

 8. Oncolytic Virus Therapy Market - Competitive Analysis

8.1. Market Share/ Rank Analysis

8.2. Key strategies adopted by market players

8.3. Product Benchmarking

 9. Oncolytic Virus Therapy Market - Company Profiles *

9.1. Amgen

9.2. Pfizer

9.3. Oncolytics Biotech

9.4. Viralytics

9.5. Transgene

9.6. AstraZeneca

9.7. Lee Pharma

9.8. Roche

9.9. Merck

9.10. SillaJen Inc.

 10. Oncolytic Virus Therapy Market - Appendix

10.1. Sources

10.2. List of Tables

10.3. Expert Panel Validation

10.4. Disclaimer

10.5. Contact Us

 

*Note: Additional company profiles will be included on client request.

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
step 1We collate your requirements.
step 2Our global research team is put into action.
step 3We deliver, and make sure your endeavour is a success!

Buy This Report